Stock Scorecard
Stock Summary for ProPhase Labs Inc (PRPH) - $0.42 as of 7/11/2025 8:49:46 PM EST
Total Score
6 out of 30
Safety Score
13 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for PRPH
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for PRPH
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for PRPH
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for PRPH
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for PRPH (13 out of 100)
Stock Price Rating (Max of 10) | 1 |
Historical Stock Price Rating (Max of 10) | 4 |
Stock Price Trend (Max of 10) | 1 |
Book Value (Max of 10) | 1 |
Book Value to Price (Max of 10) | 1 |
Analyst Buy Ratings (Max of 5) | 0 |
Analyst Strong Buy Ratings (Max of 5) | 0 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 5 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for PRPH
Financial Details for PRPH
Company Overview |
|
---|---|
Ticker | PRPH |
Company Name | ProPhase Labs Inc |
Country | USA |
Description | ProPhase Labs, Inc. is engaged in the research, development, manufacture, distribution, marketing, and sale of consumer health products and over-the-counter (OTC) dietary supplements in the United States. The company is headquartered in Garden City, New York. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 3/31/2025 |
Next Earnings Date | 8/7/2025 |
Stock Price History |
|
Last Day Price | 0.42 |
Price 4 Years Ago | 6.61 |
Last Day Price Updated | 7/11/2025 8:49:46 PM EST |
Last Day Volume | 350,276 |
Average Daily Volume | 2,940,423 |
52-Week High | 3.45 |
52-Week Low | 0.22 |
Last Price to 52 Week Low | 90.91% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 22.40 |
Sector PE | 41.70 |
5-Year Average PE | 1.94 |
Free Cash Flow Ratio | 0.00 |
Industry Free Cash Flow Ratio | 18.02 |
Sector Free Cash Flow Ratio | 33.25 |
Current Ratio Most Recent Quarter | 1.03 |
Total Cash Per Share | 0.00 |
Book Value Per Share Most Recent Quarter | 0.36 |
Price to Book Ratio | 1.17 |
Industry Price to Book Ratio | 34.60 |
Sector Price to Book Ratio | 31.09 |
Price to Sales Ratio Twelve Trailing Months | 3.06 |
Industry Price to Sales Ratio Twelve Trailing Months | 120.05 |
Sector Price to Sales Ratio Twelve Trailing Months | 35.30 |
Analyst Buy Ratings | N/A |
Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
Total Shares Outstanding | 41,541,200 |
Market Capitalization | 17,447,304 |
Institutional Ownership | 12.14% |
Dividends |
|
Ex-Dividend Date | 5/24/2022 |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.3000 |
Total Years Dividend Increasing | 0 |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 3 |
3-Year Average Dividend Yield | 5.21% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 100.00% |
3-Year Dividend Growth Rate Percentage | 9.54% |
5-Year Dividend Growth Rate Percentage | -15.66% |
All-Time Dividend Growth Rate Percentage | -15.66% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -95.20% |
Annual Earnings Growth | -217.98% |
Reported EPS 12 Trailing Months | -2.23 |
Reported EPS Past Year | -0.13 |
Reported EPS Prior Year | -2.34 |
Net Income Twelve Trailing Months | -43,133,000 |
Net Income Past Year | -53,364,000 |
Net Income Prior Year | -16,782,000 |
Quarterly Revenue Growth YOY | -39.30% |
5-Year Revenue Growth | -7.27% |
Operating Margin Twelve Trailing Months | -256.00% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 88,000 |
Total Cash Past Year | 678,000 |
Total Cash Prior Year | 1,609,000 |
Net Cash Position Most Recent Quarter | -1,746,000 |
Net Cash Position Past Year | -10,974,000 |
Long Term Debt Past Year | 11,652,000 |
Long Term Debt Prior Year | 10,258,000 |
Total Debt Most Recent Quarter | 1,834,000 |
Equity to Debt Ratio Past Year | 0.39 |
Equity to Debt Ratio Most Recent Quarter | 0.89 |
Total Stockholder Equity Past Year | 7,353,000 |
Total Stockholder Equity Prior Year | 49,383,000 |
Total Stockholder Equity Most Recent Quarter | 15,118,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -16,002,000 |
Free Cash Flow Per Share Twelve Trailing Months | -0.39 |
Free Cash Flow Past Year | -18,444,000 |
Free Cash Flow Prior Year | -14,503,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.01 |
MACD Signal | 0.00 |
20-Day Bollinger Lower Band | 0.25 |
20-Day Bollinger Middle Band | 0.36 |
20-Day Bollinger Upper Band | 0.47 |
Beta | -0.42 |
RSI | 63.44 |
50-Day SMA | 1.10 |
150-Day SMA | 5.00 |
200-Day SMA | 5.64 |
System |
|
Modified | 7/11/2025 8:39:59 AM EST |